• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

China Medical to Participate in the 46th Japan Imaging Diagnosis Symposium on the Digestive System

Posted on: Tuesday, 30 January 2007, 06:00 CST

China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets high intensity focused ultrasound ("HIFU") tumor therapy systems and advanced in-vitro diagnostic systems, today announced that it will participate in the 46th Japan Imaging Diagnosis Symposium on the Digestive System (the "Symposium"), which will be held at Tokyo Medical University on February 10, 2007. China Medical previously announced its intention to enter the Japanese market with its HIFU tumor therapy systems through a strategic partnership with Century Medical, Inc., a wholly-owned subsidiary of Itochu Corporation (TSE: 8001).

Dr. Joo Ha Hwang, M.D., Ph.D. of the Division of Gastroenterology in the Department of Medicine at the University of Washington will give a presentation on the development of HIFU technology in tumor treatment applications and will review the results of clinical studies using China Medical's HIFU tumor therapy system in China. He will also provide a preclinical evaluation of the device by investigators at the University of Washington. A live demonstration of the Company's HIFU tumor therapy system will be provided at the Symposium.

China Medical intends to apply for an Investigative Device Exemption from the U.S. Food and Drug Administration based on preclinical testing conducted at the University of Washington using the Company's HIFU tumor therapy system on pancreatic tumors. As the principal investigator for China Medical's U.S. clinical studies, Dr. Hwang has extensive clinical experience in gastroenterology with his research focused on HIFU technologies.

An archived video webcast of Dr. Hwang's presentation at the Symposium will be available for 90 days beginning on February 26, 2007 at: http://ir.chinameditech.com

About the Symposium

The Symposium is organized by the Japan Digestive System Imaging Diagnosis Research Association (the "Association"). The association has over 500 members, including surgeons, radiologists and other doctors of internal medicine. The purpose of the association is to discuss the diagnosis of medical cases related to diseases of the liver, biliary tract and pancreas through medical imaging technology. The association not only allows doctors to come together to discuss medical cases, but also develops and trains young doctors in how to diagnose diseases with medical imaging technology. For more information about the Symposium, please visit http://www.tokyo-med.ac.jp/int4/46gazou/index.html

About China Medical Technologies, Inc.

China Medical Technologies is a leading China-based medical device company that develops, manufactures and markets products using high intensity focused ultrasound for the treatment of solid cancers and benign tumors and advanced in-vitro diagnostics products using enhanced chemiluminescence immunoassay technology, to detect and monitor various diseases and disorders. For more information, please visit http://www.chinameditech.com

Safe Harbor Statement

This press release contains forward-looking statements. These statements constitute "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will,""expects,""anticipates,""future,""intends,""plans,""believes,""estimates" and similar statements. Among other things, the Company's expectations of the clinical efficacy of the HIFU tumor therapy system as set forth in this press release contain forward-looking statements. Such statements involve certain risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Further information regarding these and other risks is included in China Medical's filings with the U.S. Securities and Exchange Commission, including its annual report on Form 20-F. China Medical does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under applicable law.

Source: Business Wire

More News in this Category